Herpes Zoster Ophthalmicus with Unilateral Blepharoconjunctivitis: Clinical Presentation and Management

Aulia Dewi Priwindrasari; Hermansyah Salim

doi:10.56951/65hcat17

Herpes Zoster Ophthalmicus with Unilateral Blepharoconjunctivitis: Clinical Presentation and Management

Penulis

Aulia Dewi Priwindrasari Department of Ophthalmology, R. Said Sukanto Bhayangkara Hospital, Jakarta
Hermansyah Salim Department of Ophthalmology, R. Said Sukanto Bhayangkara Hospital, Jakarta

DOI:

https://doi.org/10.56951/65hcat17

Kata Kunci:

herpes zoster, varicella zoster virus, blepharoconjunctivitis

Abstrak

Introduction: Herpes zoster develops in individuals who have previously had chickenpox because both conditions are caused by the same virus, the varicella zoster virus (VZV). After recovering from chickenpox, the virus remains dormant in the sensory ganglia and can reactivate when the immune system becomes weakened.

Case: A 13-year-old girl presented with complaints of reddish bumps, which are reported to be itchy and painful, lasting for approximately 4 days. This patient has no history of varicella disease but exhibits symptoms of herpes zoster. Treatment is provided to suppress the progression of the disease, as well as to manage and prevent further complications.

Conclusion: Herpes zoster ophthalmicus (HZO) results from the reactivation of the VZV in the ophthalmic branch of the trigeminal nerve. Individuals with weakened immunity, particularly older adults, are at higher risk. HZO can lead to various ocular complications such as conjunctivitis, blepharoconjunctivitis, keratitis, and uveitis. Early antiviral treatment can reduce the severity and duration of symptoms, prevent complications, and minimize the risk of postherpetic neuralgia. Proper management, including antiviral therapy, pain control, and eye care, is crucial to improve clinical outcomes.

Unduhan

Baca Selengkapnya

Referensi

1. Nguyen K, Gallagher J, Hitchmoth D. Herpes zoster ophthalmicus: a teaching case report. Optometric Education 2014;39(2):65-73.

2. Jabin M, Alam Z, Chung E, et al. A case of herpes zoster ophthalmicus in a recently transplanted renal patient. Cureus 2023;15(6):e40899. doi:10.7759/cureus.40899.

3. Hakim FE, Riaz K, Farooq A. Pediatric herpes zoster ophthalmicus: a systematic review. Graefes Arch Clin Exp Ophthalmol. 2023;1:11.

4. Utami DNT, Rusyati LMM, Sudarsa PSS. Herpes zoster oftalmikus dengan komplikasi okular: laporan kasus. Intisari Sains Medis 2021;12(1):420-7.

5. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology 2008;115:S3-12.

6. Maiya AS, Shenoy S. A clinical study of herpes zoster ophthalmicus. JDMS. 2013;12(6):9-13.

7. Guess HA, Broughton DD, Melton LJ 3rd, Kurland LT. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 1985;76:512-7.

8. Leung AK, Robson WL, Leong AG. Herpes zoster in childhood. J Pediatr Health Care. 2006;20:300-3. doi:10.1016/j.pedhc.2006.01.004.

9. Shang BS, Hung CJ, Lue KH. Herpes zoster in an immunocompetent child without a history of varicella. Pediatr Rep. 2021;13:162-7.

10. Levin MJ, Schmader KE, Oxman MN. Varicella and herpes zoster. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw-Hill; 2019. p.3035-58.

11. Fatmah. Respons imunitas yang rendah pada tubuh manusia usia lanjut. Makara Kesehatan 2006;10(1):47-53.

12. Kim CK, Choi YM, Bae E, et al. Reduced NK cell IFN-γ secretion and psychological stress are independently associated with herpes zoster. PLoS One. 2018;13(2):e0193299.

13. Bricout H, Perinetti E, Marchettini P, et al. Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study. BMC Infect Dis. 2014;14:637.

14. Kong CL, Thompson RR, Porco TC, et al. Incidence rate of herpes zoster ophthalmicus: a retrospective cohort study from 1994 through 2018. Ophthalmology. 2020;127(3):324-30.

15. Pawelec G. T-cell immunity in the aging human. Haematologica 2014;99(5):795-7.

16. Vrcek I, Choudhury E, Durairaj V. Herpes zoster ophthalmicus: a review for the internist. Am J Med. 2017;130(1):21-6.

17. Wiafe B. Herpes zoster ophthalmicus in HIV/AIDS. J Comm Eye Health. 2003;16(47):35-6.

18. Andrade FMX. Clinical profile and ophthalmologic manifestations of herpes zoster ophthalmicus. Rev Bras Oftalmol. 2019;78(3):170-4.

19. Schmader K. Herpes zoster. Clin Geriatr Med. 2016;32(3):539-53.

20. Sengupta S. Cutaneous herpes zoster. Curr Infect Dis Rep. 2013;15(5):432-43.

21. Lewis K, Palileo B, Pophal C, et al. Herpes zoster ophthalmicus. Available at: https://www.aao.org/eyenet/article/herpes-zoster-ophthalmicus-pearls.

22. Sinaga D. Pengobatan herpes zoster (HZ) ophtalmica dextra dalam jangka pendek serta pencegahan postherpetic neuralgia (PHN). Jurnal Ilmiah WIDYA. 2014;2(3):23-9.

23. Sayhan MB, Sezenler E, Nalbur IH, et al. Herpes zoster ophthalmicus. JAEMCR. 2012;3:74-6.

24. Levin MJ, Schmader KE, Oxman MN. Varicella and herpes zoster. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw-Hill; 2019.